
Overview
James Gammie is the surgical lead and co-director for the Johns Hopkins Heart and Vascular Institute and cardiac surgeon-in-chief for the Johns Hopkins Health System. With over 23 years of experience in cardiothoracic surgery, Dr. Gammie joined Johns Hopkins after serving as chief of the division of cardiac surgery at the University of Maryland Medical Center from 2012 to 2021. Dr. Gammie graduated from Brown University with a degree in biochemistry, and received his medical degree from the University of Massachusetts Medical School. Dr. Gammie trained in both general and cardiothoracic surgery at the University of Pittsburgh School of Medicine. His clinical and research efforts are focused on decreasing the mortality and morbidity of valve disease and improving the surgical treatment of mitral valve and other structural heart diseases. He performs over 225 mitral valve operations and interventions per year, and leads a cardiac surgery team that performs more than 1,200 cardiac operations annually. He is recognized by the Mitral Foundation and the American Heart Association as one of less than 25 reference surgeons in the U.S. for his experience in mitral valve repair and excellent patient outcomes. Dr. Gammie has a strong interest in all aspects of heart valve disease, and has published more than 200 peer-reviewed contributions in leading specialty journals including The New England Journal of Medicine, the Journal of Thoracic and Cardiovascular Surgery and Circulation. He has served as a deputy editor for The Annals of Thoracic Surgery and as chair of the Access and Publications Committee of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. He serves on the steering committee of the NHLBI-sponsored Cardiothoracic Surgery Trials Network, and led the protocol development committee of a worldwide randomized tricuspid valve surgery trial. He is a member of the Halsted Society and the 21st Century Cardiothoracic Surgical Society. In 2011, Dr. Gammie was awarded the Johns Hopkins/University of Maryland Alliance for Science and Technology Development BioMaryland LIFE Prize, and he was named Entrepreneur of the Year at the University of Maryland Baltimore in 2014. He is the inventor of a novel transseptal catheter designed to simplify transcatheter cardiac procedures, and founded a commercial company to commercialize the device. With 20 issued or submitted patents, he continues to innovate in the mitral valve space, and recently published the world’s first clinical experience with a novel surgical repair for secondary mitral valve regurgitation, which was developed in his laboratory: mitral valve translocation. From 2016–2021, Dr. Gammie was consistently named a Top Doctor by Baltimore magazine, and in 2018 he received the Golden Apple Teacher of the Year award.
Dr. Gammie is rated as a Distinguished provider by MediFind in Embolectomy. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery.
His clinical research consists of co-authoring 195 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Embolectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
10755 Falls Road, Pavilion I STE 360, Pavilion I STE 360, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Ghoreishi is an internationally recognized expert. He brings exceptional skill in open and endovascular aortic repair, including aortic valve repair, Ross operation, valve sparing aortic root repair, innovation in minimally invasive techniques for aortic aneurysm repair, endovascular repair of high risk patients with acute type A or type B aortic dissection, and first-in-human procedures such as the Endo-Bentall repair for aortic dissection. His clinical leadership and innovation have drawn national and international referrals and advanced standards of care in this challenging field. Dr. Ghoreishi has served as Principal Investigator on several federally funded studies through the National Heart, Lung, and Blood Institute (NHLBI) and is a frequent contributor to national guidelines and surgical education symposia. Dr. Ghoreishi is rated as a Distinguished provider by MediFind in Embolectomy. His top areas of expertise are Aortic Dissection, Cystic Medial Necrosis of Aorta, Thoracic Aortic Aneurysm, Embolectomy, and Heart Bypass Surgery.
Johns Hopkins Outpatient Center
Chetan Pasrija, M.D. is a cardiothoracic surgeon in Baltimore, Maryland. He is an assistant professor of surgery at the Johns Hopkins University School of Medicine. Dr. Pasrija specializes in heart and lung transplantation, aortic surgery, and the surgical treatment of ischemic heart disease. He also has a particular interest in chronic thromboembolic pulmonary hypertension. He has published extensively on the topics of heart and lung transplant, massive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and minimally invasive left ventricular assist device implantation. As a trainee, Dr. Pasrija was heavily involved with the surgical implantation and postoperative management of the first cardiac xenotransplant performed in the world at the University of Maryland. During his time as faculty at Vanderbilt University, he was a part of one of the largest heart and lung transplant programs in the United States. This included significant involvement with cutting-edge technologies to expand the donor pool, including normothermic regional perfusion and the Transmedics Organ Care System. Dr. Pasrija was co-surgeon in a combined heart-lung transplant with a groundbreaking 9.5 hour period of time without any blood flow using a novel 10⁰C cooler. He has also performed heart transplants with travel as far as Puerto Rico. Outside of transplantation, Dr. Pasrija is a high-volume cardiac surgeon, with an interest in complex open and endovascular aortic surgery. He performed the first ascending stent in the state of Tennessee, as well as the first total arch replacement without cooling the patient’s body in Tennessee using the Thoraflex device. He earned his Bachelor of Science Degree in Bioengineering at the University of Maryland and his Medical Degree at the University of Maryland School of Medicine. He completed an Integrated Cardiothoracic Surgery residency at the University of Maryland. During his training, he spent time at Vanderbilt University to learn advanced heart failure techniques as well as time at the University of Toronto to learn advanced lung transplant and pulmonary thromboendartectomy techniques. Additionally, he has a Masters in Clinical Research from the University of Maryland. Outside of his clinical interests, Dr. Pasrija is an accomplished investigator. During his post-doctoral research fellowship, he received a competitive American Heart Association post-doctoral fellowship award in addition to institutional awards for excellence in research. His research efforts focus on improving donor preservation with novel perfusion and temperature techniques, improving donor evaluation methods, and establishing novel immunologic therapies for transplant tolerance. Dr. Pasrija is rated as a Distinguished provider by MediFind in Embolectomy. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Dissection, Embolectomy, and Heart Transplant.
University Of Maryland Pediatric Associates PA
Bartley Griffith is a Thoracic Surgeon in Baltimore, Maryland. Dr. Griffith is rated as a Distinguished provider by MediFind in Embolectomy. His top areas of expertise are Hemolysis, Aortic Valve Stenosis, Aortic Regurgitation, Embolectomy, and Aortic Valve Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mitral Valve RegurgitationDr. Gammie isElite. Learn about Mitral Valve Regurgitation.
- Distinguished
- EmbolectomyDr. Gammie isDistinguished. Learn about Embolectomy.
- Heart Bypass SurgeryDr. Gammie isDistinguished. Learn about Heart Bypass Surgery.
- Tricuspid RegurgitationDr. Gammie isDistinguished. Learn about Tricuspid Regurgitation.
- Advanced
- Coronary Artery Bypass Graft (CABG)
- EndocarditisDr. Gammie isAdvanced. Learn about Endocarditis.
- Heart Valve RepairDr. Gammie isAdvanced. Learn about Heart Valve Repair.
- Infective EndocarditisDr. Gammie isAdvanced. Learn about Infective Endocarditis.
- Mitral StenosisDr. Gammie isAdvanced. Learn about Mitral Stenosis.
- Mitral Valve ProlapseDr. Gammie isAdvanced. Learn about Mitral Valve Prolapse.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Aortic DissectionDr. Gammie isExperienced. Learn about Aortic Dissection.
- Aortic RegurgitationDr. Gammie isExperienced. Learn about Aortic Regurgitation.
- Aortic Valve ReplacementDr. Gammie isExperienced. Learn about Aortic Valve Replacement.
- Aortic Valve StenosisDr. Gammie isExperienced. Learn about Aortic Valve Stenosis.
- Arterial EmbolismDr. Gammie isExperienced. Learn about Arterial Embolism.

